Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Guaranteed Paid Placement
    • Cision Media Monitoring
    • Multichannel Amplification
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Multichannel Amplification
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Cision IR
  • SocialBoost
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

CI Labs Launches Singapore's First Homegrown Pharmacopoeia-Grade, Traditional-Medicine-Inspired Eczema Relief Cream, Offering a Gentle, Non-Steroidal Option for Sensitive Skin


News provided by

CI Labs Singapore Pte Ltd

26 Jan, 2026, 10:18 CST

Share this article

Share toX

Share this article

Share toX

Formulated with 12 pharmacopoeia-grade botanicals, the new cream is designed to support eczema-prone and sensitive skin for young children and adults seeking a non-steroidal option.

SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- CI Labs, a Singapore-based wellness brand focused on gentle and effective skincare, announced the launch of its CI Labs Eczema Relief Cream, a non-steroidal formulation developed to support eczema-prone and sensitive skin.

Formulated with 12 pharmacopoeia-grade botanicals traditionally used to help soothe irritation and support skin comfort, the cream is designed for families looking for a gentle, non-steroidal alternative to steroid-based products.

Developed in collaboration with certified skincare laboratories and inspired by traditional herbal medicine, CI Labs Eczema Relief Cream is free from steroids, parabens, and artificial fragrances. It is designed for use by children and adults, and is suitable for infants from six months of age when used as directed.

Each production batch undergoes independent third-party screening by ALS Ltd, a publicly listed global testing laboratory, for a comprehensive panel including steroids, antihistamines, antibiotics, heavy metals, poisons, and other potential contaminants.

Founded from a Personal Journey to Find Gentler Care

CI Labs was founded following the personal journey of its founder, who spent over two decades managing chronic eczema and the longer-term concerns often associated with steroid-based care. The turning point came when his young daughter began showing early signs of eczema, prompting a renewed search for a gentler, non-steroidal option suitable for long-term family use.

Driven by this mission, the CI Labs team collaborated with certified laboratories, senior medical professionals, and traditional medicine practitioners to research and refine a formulation grounded in traditional herbal knowledge and modern quality standards. Particular emphasis was placed on ingredient consistency, sourcing integrity, and safety, recognising that botanical quality can depend on geo-authenticity, purity, and controlled cultivation and processing practices.

This approach ultimately led to the development of CI Labs Eczema Relief Cream — a formulation designed to support skin comfort while meeting stringent quality and testing standards.

A CI Labs spokesperson said: "Families today want solutions that are effective yet gentle enough for young children. CI Labs was created to bridge that gap with a formulation that brings both comfort and confidence. Our mission is simple: it's where hope meets healing."

A Carefully Curated Blend of 12 Pharmacopoeia-Grade Botanicals

Each CI Labs Eczema Relief Cream formulation is crafted using botanicals selected for their traditional skincare applications, with strict controls on geo-authenticity, genetic integrity, and environmental contaminants at source. Key ingredients include:

  • Chamomile (Matricaria chamomilla): Traditionally used to help soothe irritated-looking skin.
  • Purple gromwell root (Lithospermum erythrorhizon): Traditionally used in topical preparations for skin comfort.
  • Tea tree (Melaleuca alternifolia): Commonly used in skincare for its cleansing properties.
  • Chinese gall (Rhus chinensis): Traditionally valued for its astringent properties.
  • Golden larch bark (Pseudolarix kaempferi): Traditionally used to help relieve itchiness.
  • Smilax glabra: Traditionally used to support skin clarity.
  • Arisaema (Arisaema erubescens): Traditionally used in preparations associated with "detumescence" (swelling-related support).
  • Chinese mint (Mentha haplocalyx): Traditionally valued for a cooling skin feel.
  • Grape leaf (Vitis vinifera): Traditionally associated with venous circulation support.
  • Evodia (Evodia rutaecarpa): Traditionally used and studied for anti-inflammatory support.
  • Red sage root (Salvia miltiorrhiza): Traditionally used to support circulation.
  • Cnidium monnieri: Traditionally used to help relieve itchiness.

Together, these botanicals form a modern, non-steroidal skincare formulation designed to support skin comfort and resilience.

Formulated for Singapore's Climate

Recognising that heat and humidity can aggravate sensitive skin, CI Labs Eczema Relief Cream is designed to:

  • Absorb quickly without greasiness
  • Provide a light, cooling skin feel
  • Support the skin barrier against sweat- and heat-related irritation

Availability & Pricing

CI Labs Eczema Relief Cream is now available via:

  • Official Online Store: www.mycilabs.com
  • TikTok Shop: @mycilabs
  • Instagram: @mycilabs

Product Formats & Pricing:

  • 30ml Full-Size Bottle: SGD 69
  • Triple Pack (3 × 30ml): SGD 177
  • Subscription Plan: SGD 49 per bottle
    (Minimum six-month subscription; billed per renewal cycle.)

About CI Labs

CI Labs is a Singapore wellness brand dedicated to creating gentle, effective, and science-supported skincare inspired by traditional herbal wisdom. All products are developed in certified laboratories using pharmacopoeia-grade botanicals and dermatologist-guided formulation standards.

CI Labs' guiding mission is simple: Where Hope Meets Healing — supporting comfort, confidence, and care for families managing sensitive and eczema-prone skin.

SOURCE CI Labs Singapore Pte Ltd

Modal title

Contact Cision

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2025 Cision US Inc.